Not Yet RecruitingNot Applicable

Study of a Smart Sharps Disposal Device in Patients With Hemophilia

United States23 participantsStarted 2026-05-01

Plain-language summary

This pilot study will have patients use a smart sharps disposal container at home for disposal of needles used to administer their hemophilia drugs. The study aims to find out if the smart sharps container proved acceptable to use by patients and medical providers and can be adhered to.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion: * Male or female, ≥18 years of age * Moderate or Severe Hemophilia A or B, with or without an inhibitor * Prescribed prophylaxis with either a factor product or emicizumab that is scheduled to be given at least once every 14 days Exclusion: * Stated inability to use the SharpsCue container * Treatment with another investigational drug or other intervention during the study period * Patients on prophylactic dosing less than once every 14 days * Patients who are infused by a home nurse

What they're measuring

Adherence

Timeframe: Days 1-180

Trial details

NCT IDNCT07421154

SponsorUniversity of Pennsylvania

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-01-30

Contact for this trial

Allyson Pishko, MD

215-615-6555 Allyson.Pishko@pennmedicine.upenn.edu

View on ClinicalTrials.gov More Hemophilia A and B trials